N08.34 ICD-10-CA code: Glomerular disorders in diabetes mellitus, chronic kidney disease, stage 4

N08.34 is the ICD-10-CA code for “Glomerular disorders in diabetes mellitus, chronic kidney disease, stage 4” in CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026.

Official description

N08.34

Glomerular disorders in diabetes mellitus, chronic kidney disease, stage 4

Short description: Glomer dis in diabetes chron kid stage 4

ICD-10-CA · Canada · Also written N0834

Notes for N08.34

As CIHI prints them, with any note N08.34 takes from the headings above it.

Includes

Use additional code

Add a code for this detail when the note documents it.

Excludes

Conditions classified elsewhere.

  • Renal tubulo-interstitial disorders in diseases classified elsewhere (N16.-*)From N08 Glomerular disorders in diseases classified elsewhere
  • Hypertensive renal disease (I12)From N00-N08 Glomerular diseases
  • Certain conditions originating in the perinatal period (P00-P96)certain infectious and parasitic diseases (A00-B99)complications of pregnancy, childbirth and the puerperium (O00-O99)congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)endocrine, nutritional and metabolic diseases (E00-E90)injury, poisoning and certain other consequences of external causes (S00-T98)neoplasms (C00-D48)symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)From Chapter 14: Diseases of the genitourinary system (N00-N99)

Note

  • The following fourth-character subdivisions classify morphological changes and are for use with categories N00 - N07. Subdivisions .0 - .8 should not normally be used unless these have been specifically identified (e.g. by renal biopsy or autopsy). The three-character categories relate to clinical syndromes..0 Minor glomerular abnormalityMinimal change lesion.1 Focal and segmental glomerular lesionsGlomerulonephritis, Hyalinosis, Sclerosis — focal and segmental.2 Diffuse membranous glomerulonephritis.3 Diffuse mesangial proliferative glomerulonephritis.4 Diffuse endocapillary proliferative glomerulonephritis.5 Diffuse mesangiocapillary glomerulonephritisMembranoproliferative glomerulonephritis, types 1 and 3, or NOS.6 Dense deposit diseaseMembranoproliferative glomerulonephritis, type 2.7 Diffuse crescentic glomerulonephritisExtracapillary glomerulonephritis.8 OtherProliferative glomerulonephritis NOS.9 UnspecifiedFrom N00-N08 Glomerular diseases

Where N08.34 sits

  1. 1ChapterChapter 14: Diseases of the genitourinary system (N00-N99)
  2. 2Block N00-N08Glomerular diseases
  3. 3Category N08Glomerular disorders in diseases classified elsewhere
  4. 4Subcategory N08.3Glomerular disorders in diabetes mellitus
  5. 5Valid code N08.34Glomerular disorders in diabetes mellitus, chronic kidney disease, stage 4

Source and release

Data release
ICD-10-CA · FY 2026–2027
Effective date
Apr 1, 2026
Publisher
CIHI

This page is built from the ICD-10-CA catalog that Vero Codes reads when it suggests codes: Canadian Institute for Health Information’s FY 2026–2027 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does ICD-10-CA code N08.34 mean?

N08.34 is the ICD-10-CA code for “Glomerular disorders in diabetes mellitus, chronic kidney disease, stage 4” in CIHI’s ICD-10-CA FY 2026–2027 release.

Where is N08.34 in ICD-10-CA?

N08.34 sits under N08.3 Glomerular disorders in diabetes mellitus, within N08 Glomerular disorders in diseases classified elsewhere, within N00-N08 Glomerular diseases, within Chapter 14: Diseases of the genitourinary system (N00-N99).

What coding notes apply to N08.34?

ICD-10-CA lists Includes, Excludes, Note, Use additional code notes for N08.34, including those from the headings it sits under. They are listed on this page with where each one comes from.

Which ICD-10-CA release does this page use?

It uses CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026 to Mar 31, 2027. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.